Capsule Summary Slidesets

Share

Program Content

Activities

  • CARISEL Interim Results
    CARISEL Interim Results: Acceptability, Appropriateness, Feasibility, Barriers, and Facilitators of LA CAB + RPV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 02, 2021

    Expires: November 01, 2022

  • IMEA 055 FAST: Rapid BIC/FTC/TAF
    IMEA 055 FAST: BIC/FTC/TAF for Rapid Initiation of ART in Test-and-Treat Model
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 02, 2021

    Expires: November 01, 2022

  • SOLAR 3D: Wk 48 Results
    SOLAR 3D: Wk 48 Results of Switching to DTG/3TC From Suppressive 3- or 4-Drug ART in PWH With M184V/I Mutations and Virologic Failure
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 02, 2021

    Expires: November 01, 2022

  • DOR in Tx-Naive Patients
    DRIVE-FORWARD and DRIVE-AHEAD: Safety and Efficacy of Doravirine in Treatment-Naive Adults at 4 Yr
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2021

    Expires: November 02, 2022

  • MAVMET
    MAVMET: Maraviroc ± Metformin for the Treatment of NAFLD in Virologically Suppressed Adults With HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2021

    Expires: November 02, 2022

  • Protocol 011: Week 144
    Protocol 011 at Wk 144: Islatravir + Doravirine in Treatment-Naive Persons With HIV
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2021

    Expires: November 02, 2022

  • TANGO IL-6 Study
    TANGO: Associations Between IL-6 and HIV-1 RNA Levels After Switch to DTG/3TC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 04, 2021

    Expires: November 03, 2022

  • Lenacapavir Resistance
    CAPELLA: Resistance Analysis in Highly Treatment–Experienced Patients Receiving LA Lenacapavir
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2021

    Expires: November 04, 2022

  • LA CAB + RPV: Outcomes by BMI
    Combined Analysis of ATLAS, FLAIR, ATLAS-2M: Efficacy and Safety of Switch to LA CAB + RPV by BMI Class
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 05, 2021

    Expires: November 04, 2022

  • ANRS Prévenir: Renal Safety
    ANRS Prévenir: Renal Safety of Different TDF/FTC Dosing Regimens for HIV PrEP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare